Your browser doesn't support javascript.
loading
Preparation, physicochemical properties, in vitro evaluation and release behavior of cephalexin-loaded niosomes.
Ghafelehbashi, Robabehbeygom; Akbarzadeh, Iman; Tavakkoli Yaraki, Mohammad; Lajevardi, Aseman; Fatemizadeh, Mahdi; Heidarpoor Saremi, Leily.
Afiliação
  • Ghafelehbashi R; Department of Materials and Textile Engineering, College of Engineering, Razi University, Kermanshah, Iran.
  • Akbarzadeh I; Department of Chemical and Petrochemical Engineering, Sharif University of Technology, Tehran, Iran. Electronic address: iman.akbarzadeh@che.sharif.edu.
  • Tavakkoli Yaraki M; Department of Chemical and Biomolecular Engineering, National University of Singapore, 4 Engineering Drive 4, Singapore 117585, Singapore; Institute of Materials Research and Engineering (IMRE), The Agency for Science, Technology and Research (A*STAR), 2 Fusionopolis Way, #08-03, Innovis 138634, Sin
  • Lajevardi A; Department of Chemistry, Science and Research Branch, Islamic Azad University, Tehran, Iran.
  • Fatemizadeh M; School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Heidarpoor Saremi L; Department of Chemistry, Faculty of Science, University of Sistan and Baluchestan, Zahedan, Iran.
Int J Pharm ; 569: 118580, 2019 Oct 05.
Article em En | MEDLINE | ID: mdl-31374239
In this study, optimized cephalexin-loaded niosomal formulations based on span 60 and tween 60 were prepared as a promising drug carrier system. The niosomal formulations were characterized using a series of techniques such as scanning electron microscopy, Fourier transformed infrared spectroscopy, dynamic light scattering, and zeta potential measurement. The size and drug encapsulation efficiency are determined by the type and composition of surfactant. The developed niosomal formulations showed great storage stability up to 30 days with low change in size and drug entrapment during the storage, making them potential candidates for real applications. Moreover, the prepared niosomes showed negligible cytotoxicity for HepG2 cells, measured by MTT assay. The antibacterial properties of cephalexin-loaded niosome were investigated using S. aureus and E. coli as gram-positive and gram-negative bacteria, respectively. The results showed that the encapsulation of antibiotic drug in niosomal formulation could enhance the antibacterial efficiency of the drug, where the minimum inhibitory concentration was droped from 8 µg/mL (cephalexin) to 4 µg/mL (cephalexin-loaded niosome) and from 4 µg/mL (cephalexin) to 1 µg/mL (cephalexin-loaded niosome) against E. coli and S. aureus, respectively. The findings of our study show that the improvement of cephalexin bioavailability and prolonged drug release profile could be obtained by niosomal formulation as a favorable antibiotic drug delivery system.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Staphylococcus aureus / Cefalexina / Escherichia coli / Antibacterianos Limite: Humans Idioma: En Revista: Int J Pharm Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Irã

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Staphylococcus aureus / Cefalexina / Escherichia coli / Antibacterianos Limite: Humans Idioma: En Revista: Int J Pharm Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Irã